DelveInsight's“Ocular melanoma Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Ocular melanoma, historical and forecasted epidemiology as well ...

For this purpose, the researchers assessed the incidence, risk factors, and outcomes of melanoma among participants in the ...

Childhood cancer survivors had greater than twofold increased risk of invasive skin and ocular melanoma (95% CI 1.6-2.4) ...

Cancers of the eye are exceedingly rare, and only a rare handful of cancer clinics in the nation are equipped to deal with ...

A mum-of-two has been left fighting for her life after a routine eye test revealed a devastating diagnosis.

The firm is expanding its melanoma portfolio while launching new trials of T-cell receptor therapies in oncology, infectious disease, and autoimmune disease.

Reaching more mUM patients globally with KIMMTRAK (tebentafusp) in 2025 through additional launches and increased community penetrationEnrolling ...

Tanning beds are classified by International Agency for Research on Cancer (IARC) in the highest risk category, Group 1: ...

It was back in 2017 when Steve Lynch first noticed a little spot on the white part (the sclera) of his right eye. “It wasn’t ...

Neratinib is under clinical development by Puma Biotechnology and currently in Phase II for Ocular Melanoma. According to GlobalData, Phase II drugs for Ocular Melanoma have a 28% phase transition ...

Jade has had to learn the nuances of caring for patients with salivary duct carcinoma, ocular melanoma, Merkel cell carcinoma and sarcomas with strange names, such as pseudomyogenic ...